
Speakers

Tiffany A. Traina, MD
Memorial Sloan Kettering Cancer Center, USA
Dr. Tiffany A. Traina is an Associate Attending Physician and Clinical Director of the Breast Medicine Service at Memorial Sloan Kettering. She serves as the Section Head of the Triple Negative Breast Cancer Clinical Research Program. She is also Assistant Professor of Medicine at Weill Cornell Medicine in New York City. Her research program centers on the development of therapies for patients with breast cancers, with a particular focus on Triple Negative Breast Cancer and the role of the androgen receptor in breast cancers. Dr. Traina has served on the ASCO Scientific Program Committee for the Triple Negative Breast Cancer/Cytotoxics/Local Therapy track as well and is a member of the Translational Breast Cancer Research Consortium Triple Negative Breast Cancer Working Group. In addition, Dr. Traina is a member of the 2016-2017 ASCO Leadership Development Program. She now serves on the ASCO Membership Committee and is an advisor on the Breast Cancer Guidelines Advisory Group. Her research efforts have earned her the Hally Yaccino Steiner Award from the Susan G. Komen Breast Cancer Foundation. She has received teaching awards from Memorial Sloan Kettering and Weill Cornell Medicine and the 2014 Hero Award from the Triple Negative Breast Cancer Foundation.